GOLDENWELL BIOTECH, INC. (GWLL)

Every figure this model derived for GWLL, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 11,143 CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents 2026-06-30
current assets 250,544 AssetsCurrent 2020-09-30
current liabilities 100,000 LiabilitiesCurrent 2026-06-30
equity -398,195 StockholdersEquity 2026-06-30
interest expense 8,400 InterestExpense 2026-03-31
ocf -110,365 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 55 Revenues 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up GWLL on one particular measure came for.

RatioValue
current ratio2.51
current ratio reported2.51
deferred revenue growth-100.0
dilution pct0.0
interest cover-13.67
sbc pct revenue0.0

What to be careful about

What this model itself distrusts about GWLL's figures. Written by the derivation as it ran, not added afterwards.